Merve Postalcioglu , Rebecca Scherzer , Joachim H. Ix , David R. Jacobs Jr , Cora E. Lewis , Sucheta Vaigankar , Michelle M. Estrella , Orlando M. Gutierrez , Michael G. Shlipak
{"title":"Urine Epidermal Growth Factor and Kidney Function Decline in Middle-Aged Adults","authors":"Merve Postalcioglu , Rebecca Scherzer , Joachim H. Ix , David R. Jacobs Jr , Cora E. Lewis , Sucheta Vaigankar , Michelle M. Estrella , Orlando M. Gutierrez , Michael G. Shlipak","doi":"10.1016/j.xkme.2024.100846","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale & Objective</h3><p>The diagnosis and prognostication of chronic kidney disease (CKD) largely rely on glomerular measures that may not reflect tubular damage. We investigated the associations of urine kidney tubule biomarkers with estimated glomerular filtration rate (eGFR) change among middle-aged adults, when chronic diseases typically emerge.</p></div><div><h3>Study Design</h3><p>An observational cohort study.</p></div><div><h3>Setting & Participants</h3><p>A total of 1,145 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study without CKD, hypertension, or cardiovascular disease at the year 20 visit.</p></div><div><h3>Exposures</h3><p>Seven different biomarkers of tubular health: urine epidermal growth factor (EGF), alpha-1-microglobulin (α1m), interleukin-18, kidney injury molecule-1, monocyte chemoattractant protein-1, uromodulin, and chitinase-3-like protein 1.</p></div><div><h3>Outcomes</h3><p>Ten-year eGFR change and incident reduced eGFR (new onset of eGFR<!--> <!--><<!--> <!-->60<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>).</p></div><div><h3>Analytical Approach</h3><p>We examined associations of tubular health biomarkers with 10-year eGFR change and incident reduced eGFR with linear mixed models and interval-censored proportional hazards regression models, respectively. Both minimally and fully adjusted models were controlled for urine creatinine levels.</p></div><div><h3>Results</h3><p>The mean age of participants was 44.8<!--> <!-->±<!--> <!-->3.7 years, with 39% African American and 56% female. The average 10-year change in eGFR was -18.6<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> (95% CI, -19.4 to -17.8). In contrast to the other tubular biomarkers, which showed conflicting results, EGF demonstrated strong, consistent associations with both kidney outcomes. Each 1-standard deviation (SD) higher EGF was associated with a 2.37<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> (95% CI, 0.64-4.10) smaller 10-year decrease in eGFR and a 42% (95% CI, 4%-64%) lower risk of incident reduced eGFR in the fully adjusted model.</p></div><div><h3>Limitations</h3><p>Observational design, measurements of eGFR were done only at 5-year intervals during follow-up.</p></div><div><h3>Conclusions</h3><p>In middle-aged, community-dwelling adults without hypertension, cardiovascular disease or CKD, higher urine EGF concentrations are associated with slower eGFR decline, whereas other kidney tubule biomarkers lacked a consistent association with kidney function decline.</p></div><div><h3>Plain Language Summary</h3><p>Current measures of chronic kidney disease (CKD) rely on markers of glomerular health and function. This approach inadequately captures the role of kidney tubule health, a known histopathological predictor of CKD development. We investigated associations of 7 biomarkers of kidney tubule health with 10-year estimated glomerular filtration rate (eGFR) change and incident reduced eGFR. Among 7 biomarkers, only epidermal growth factor showed persistent and inverse associations with both 10-year eGFR change and incident reduced eGFR. These findings suggest that epidermal growth factor has an association with kidney function changes and might play a protective role in kidney disease development.</p></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590059524000578/pdfft?md5=63afe19094ca813342c047a024fd52cf&pid=1-s2.0-S2590059524000578-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524000578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale & Objective
The diagnosis and prognostication of chronic kidney disease (CKD) largely rely on glomerular measures that may not reflect tubular damage. We investigated the associations of urine kidney tubule biomarkers with estimated glomerular filtration rate (eGFR) change among middle-aged adults, when chronic diseases typically emerge.
Study Design
An observational cohort study.
Setting & Participants
A total of 1,145 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study without CKD, hypertension, or cardiovascular disease at the year 20 visit.
Exposures
Seven different biomarkers of tubular health: urine epidermal growth factor (EGF), alpha-1-microglobulin (α1m), interleukin-18, kidney injury molecule-1, monocyte chemoattractant protein-1, uromodulin, and chitinase-3-like protein 1.
Outcomes
Ten-year eGFR change and incident reduced eGFR (new onset of eGFR < 60 mL/min/1.73 m2).
Analytical Approach
We examined associations of tubular health biomarkers with 10-year eGFR change and incident reduced eGFR with linear mixed models and interval-censored proportional hazards regression models, respectively. Both minimally and fully adjusted models were controlled for urine creatinine levels.
Results
The mean age of participants was 44.8 ± 3.7 years, with 39% African American and 56% female. The average 10-year change in eGFR was -18.6 mL/min/1.73 m2 (95% CI, -19.4 to -17.8). In contrast to the other tubular biomarkers, which showed conflicting results, EGF demonstrated strong, consistent associations with both kidney outcomes. Each 1-standard deviation (SD) higher EGF was associated with a 2.37 mL/min/1.73 m2 (95% CI, 0.64-4.10) smaller 10-year decrease in eGFR and a 42% (95% CI, 4%-64%) lower risk of incident reduced eGFR in the fully adjusted model.
Limitations
Observational design, measurements of eGFR were done only at 5-year intervals during follow-up.
Conclusions
In middle-aged, community-dwelling adults without hypertension, cardiovascular disease or CKD, higher urine EGF concentrations are associated with slower eGFR decline, whereas other kidney tubule biomarkers lacked a consistent association with kidney function decline.
Plain Language Summary
Current measures of chronic kidney disease (CKD) rely on markers of glomerular health and function. This approach inadequately captures the role of kidney tubule health, a known histopathological predictor of CKD development. We investigated associations of 7 biomarkers of kidney tubule health with 10-year estimated glomerular filtration rate (eGFR) change and incident reduced eGFR. Among 7 biomarkers, only epidermal growth factor showed persistent and inverse associations with both 10-year eGFR change and incident reduced eGFR. These findings suggest that epidermal growth factor has an association with kidney function changes and might play a protective role in kidney disease development.